AZD5438-PROTAC: A selective CDK2 degrader that protects against cisplatin- and noise-induced hearing loss.

MLA

Hati, Santanu, et al. “AZD5438-PROTAC: A Selective CDK2 Degrader That Protects against Cisplatin- and Noise-Induced Hearing Loss.” European Journal of Medicinal Chemistry, vol. 226, Dec. 2021, p. 113849. EBSCOhost, https://doi.org/10.1016/j.ejmech.2021.113849.

APA

Hati, S., Zallocchi, M., Hazlitt, R., Li, Y., Vijayakumar, S., Min, J., Rankovic, Z., Lovas, S., & Zuo, J. (2021). AZD5438-PROTAC: A selective CDK2 degrader that protects against cisplatin- and noise-induced hearing loss. European Journal of Medicinal Chemistry, 226, 113849. https://doi.org/10.1016/j.ejmech.2021.113849

Chicago

Hati, Santanu, Marisa Zallocchi, Robert Hazlitt, Yuju Li, Sarath Vijayakumar, Jaeki Min, Zoran Rankovic, Sándor Lovas, and Jian Zuo. 2021. “AZD5438-PROTAC: A Selective CDK2 Degrader That Protects against Cisplatin- and Noise-Induced Hearing Loss.” European Journal of Medicinal Chemistry 226 (December): 113849. doi:10.1016/j.ejmech.2021.113849.